Further investigations have revealed that upregulation of miR-133b expression in BC can inhibit a range of cancer-promoting processes, such as glucose uptake, invasion, angiogenesis, and colony formation, by targeting TAGLN2 (100). Here, TAGLN2 is linked to breast cancer.